Molecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory Infections
Comunicato Precedente
Comunicato Successivo
Globally, there currently is a disparity in laboratories' ability to participate in comprehensive pathogen surveillance. Limited access to advanced genomic technologies poses a significant obstacle, particularly in LMICs. Molecular Loop will utilize this grant to develop and evaluate a multiplex NGS assay for the genomic analysis of the causative agents of respiratory infections. Through strategic partnerships and innovative technology, Molecular Loop aims to overcome technical barriers of existing methodologies and empower laboratories in LMICs to actively participate in global viral surveillance efforts.
Molecular Loop Biosciences, Inc. looks forward to the positive impact this project will have on global health and anticipates sharing progress updates with esteemed stakeholders, including the US CDC, AfricaCDC, WHO, and others.
About Molecular Loop
Molecular Loop tailors customized targeted next-generation sequencing solutions using its unique technology that delivers industry-leading workflow simplicity without sacrificing data quality. The company leverages its technology and deep genomic expertise to accelerate innovations in life sciences and make advancements in personalized healthcare. The team is passionate about making it easier than ever for labs to harness the power of genomic technology and make genetic testing broadly accessible.
Contacts
info@molecularloop.com
Logo - https://mma.prnewswire.com/media/2296929/Molecular_Loop_Biosciences_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/molecular-loop-biosciences-receives-1-8-million-to-expand-multi-pathogen-genomics-products-for-respiratory-infections-302013750.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
